Acute diarrhea resident survival guide: Difference between revisions

Jump to navigation Jump to search
Mugilan Poongkunran (talk | contribs)
No edit summary
Mugilan Poongkunran (talk | contribs)
No edit summary
Line 27: Line 27:
==Management==
==Management==
{{familytree/start |summary=Acute Diarrhea Algorithm}}
{{familytree/start |summary=Acute Diarrhea Algorithm}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | A01 = Adults with acute diarrhea (<4 wks)}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | A01 = Adults with acute diarrhea (<4 weeks)}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01 = [[Acute diarrhea resident survival guide#History and Physical Examination|History and physical examination]] }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01=<div style="float: left; text-align: left; line-height: 150% "> '''Obtain a brief history:'''
----
❑ Onset <br> ❑ Duration <br> ❑ Pattern (Continuous or intermittent) <br> ❑ Type (Watery, bloody or fatty) <br> ❑ Fever <br> ❑ Abdominal pain <br> ❑ Nausea and vomiting <br> ❑ Weight loss <br> ❑ Epidemiological factors (Travel H/O, dietary H/O, outbreaks, seasons, institutionalization or sexual H/O) <br> ❑ Previous evaluations (Medications, radiation therapy or surgery) <br> ❑ Underlying medical condition (Cancer, diabetes, hyperthyroidism or other conditions)
----
''' Examine the patient
----
❑ General condition <br>
❑ Level of consciousness <br>
❑ Ability to drink <br>
❑ Pulse <br>
❑ Blood pressure <br>
❑ Respiratory rate <br>
❑ Eyes <br>
❑ Skin turgor <br>
❑ Mucosa</div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01 = [[Acute diarrhea resident survival guide#Evaluation of Volume Status by Dhaka Method|Assessment of volume status]] }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01 = [[Acute diarrhea resident survival guide#Evaluation of Volume Status by Dhaka Method|Assessment of volume status]] }}
Line 35: Line 49:
{{familytree | | | | | | | | | D01 | | | | | | | | | | | | | | D02 | | | | | | | | | | | | | | D03 | D01 = No dehydration | D02 = Some dehydration | D03 = Severe dehyration}}
{{familytree | | | | | | | | | D01 | | | | | | | | | | | | | | D02 | | | | | | | | | | | | | | D03 | D01 = No dehydration | D02 = Some dehydration | D03 = Severe dehyration}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | E01 | | | | | | | | | | | | | | E02 | | | | | | | | | | | | | | E03 | E01 = [[Acute diarrhea resident survival guide#Altered Diet|Altered diet]] +/- [[Acute diarrhea resident survival guide#Oral Rehydration Therapy|ORT]] | E02 = [[Acute diarrhea resident survival guide#Oral Rehydration Therapy|ORT]] + [[Acute diarrhea resident survival guide#Altered Diet|altered diet]] + reassess status every 4 hr | E03 = Start IVFs, Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use NS, [[CBC]], [[electrolytes]] + Assess status every 15 mins until strong pulse felt and then every 1 hr + Start ORT when the Pt is stable and able to drink + then assess status every 4 hr}}
{{familytree | | | | | | | | | E01 | | | | | | | | | | | | | | E02 | | | | | | | | | | | | | | E03 | E01 = <div style="float: left; text-align: left; line-height: 150% "> '''Start altered diet:'''
----
❑ Stop lactose products <br> ❑  Avoid alcohol and high osmolar supplements <br> ❑ Drink 8-10 large glasses of clear fluids (Fruit juices, soft drinks etc) <br> ❑ Eat frequent small meals (Rice, potato, banana, pastas etc) <br>
----
Can start [[oral rehydration therapy]] (ORT) for replacement of stool losses </div> | E02 = ❑ Start ORT at a volume of 50-100 mL/kg <br> ❑ Start altered diet <br> ❑ Reassess status every 4 hr | E03 = Start IV fluids: Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use normal saline <br> ❑ [[CBC]]<br> ❑ [[Electrolytes]] <br> ❑ Assess status every 15 mins until strong pulse felt and then every 1 hr <br> }}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | E03 | | E03 = Patient stable and able to drink}}
{{familytree | | | | | | | | | |`|-|-|-|-|-|-|-|v|-|-|-|-|-|-|-|'| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | |`|-|-|-|-|-|-|-|v|-|-|-|-|-|-|-|'| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | | | | | | | | | F01 | | | | | | | | | | | | | | | | | | | | | | |!| | F01 = [[Acute diarrhea resident survival guide#Warning Signs|Warning signs]]}}
{{familytree | | | | | | | | | | | | | | | | | F01 | | | | | | | | | | | | | | | | | | | | | | F03 | F01 = <div style="float: left; text-align: left; line-height: 150% "> '''Check for the following warning signs:'''
----
❑ Temperature ≥38.5ºC (101.3ºF)  <br> ❑  Severe abdominal pain <br> ❑ Bloody diarrhea <br> ❑ Passage of ≥6 unformed stools per 24 hours <br> ❑ Acute presentation of persistent diarrhea <br> ❑  Diarrhea in the elderly (≥70 years of age)  <br> ❑ Immunocompromised  <br> ❑ Hospital-acquired  <br>
</div> | F03 = ❑ Start ORT at a volume of 100 mL/kg over 4 hour <br> ❑ Calculate the continuing stool and emesis losses every hour for additional maintenance ORT therapy ❑ Reassess status every 4 hr}}
{{familytree | | | | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | G01 | | | | | | | | | | | | | | G02 | | | | | | | | | | | | | | |!| | G01 = NO | G02 = YES}}
{{familytree | | | | | | | | | G01 | | | | | | | | | | | | | | G02 | | | | | | | | | | | | | | |!| | G01 = NO | G02 = YES}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | H01 | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | H01 = [[Acute diarrhea resident survival guide#Anti-motility Drugs|Loperamide (4-6 mg/day)]]}}
{{familytree | | | | | | | | | H01 | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | H01 = <div style="float: left; text-align: left; line-height: 150% "> '''Anti-motility drugs:'''
----
❑ [[Loperamide]]: Two tablets (4 mg) initially, then 2 mg after each unformed stool  OR <br> ❑  [[Bismuth subsalicylate]], 30 mL or two tablets every 30 minutes for eight doses <br> </div>}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |)|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|'| |}}
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |)|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|'| |}}
{{familytree | | | | | | | | | I01 | | | | | | | | | | | | | | |!| | I01 = Assess the pt in 24 hrs}}
{{familytree | | | | | | | | | I01 | | | | | | | | | | | | | | |!| | I01 = Assess the pt in 24 hrs}}
{{familytree | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | |!| |}}
{{familytree | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | |!| |}}
{{familytree | J01 | | | | | | | | | | | | | | J02 |-|-|-|-|-| J03 | J01 = Resolved | J02 = Unresolved | J03 = Investigations}}
{{familytree | J01 | | | | | | | | | | | | | | J02 |-|-|-|-|-|-|!| | J01 = Resolved | J02 = Unresolved}}
{{familytree | |!| | | | | | | | | | | | | | | | | | | | | | | |!| |}}
{{familytree | |!| | | | | | | | | | | | | | | | | | | | | | | |!| |}}
{{familytree | K01 | | | | | | | | | | | | | | | | | | | | | | K02 | K01 = Gradually add solid foods to diet | K02 = [[CBC]], electrolytes, UA, <BR> fecal WBC, [[Fecal occult blood|fecal OBT]]}}
{{familytree | K01 | | | | | | | | | | | | | | | | | | | | | | K02 | K01 = Gradually add solid foods to diet | K02 = <div style="float: left; text-align: left; line-height: 150% "> '''Order investigations:'''
----
[[CBC]] <br>
❑ [[Serum electrolytes]] <br>
❑ [[Urinalysis ]] <br>
❑ [[BUN]]  <br>
❑ [[Creatinine]]  <br>
[[Fecal occult blood|Fecal occult blood (OBT)]]<br>
❑ fecal WBC <br>
</div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | K03 |-|-|-|-|-|K04|-|-|-| K05 |K03 = [[Anemia]], [[thrombocytopenia]], elevated [[BUN]] and [[creatinine]] | K04 = YES | K05 = [[EHEC|E. coli O157:H7 suspicion]], stool culture and ELISA for Shiga toxin and [[Hemolytic-uremic syndrome medical therapy|supportive care]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | K03 |-|-|-|-|-|K04|-|-|-| K05 |K03 = [[Anemia]], [[thrombocytopenia]], elevated [[BUN]] and [[creatinine]] | K04 = YES | K05 = [[EHEC|E. coli O157:H7 suspicion]], stool culture and ELISA for Shiga toxin and [[Hemolytic-uremic syndrome medical therapy|supportive care]]}}
Line 57: Line 91:
{{familytree | | | | | | | | | | | | | | | | | M01 | | | | | | | | | | | | | | M02 | | M01 = Non-inflammatory | M02 = Inflammatory}}
{{familytree | | | | | | | | | | | | | | | | | M01 | | | | | | | | | | | | | | M02 | | M01 = Non-inflammatory | M02 = Inflammatory}}
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | |}}
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | |}}
{{familytree | | | | | | | | | | | | | | | | | N01 | | | | | | | | | | | | | | N02 | | N01 = Symptomatic Rx | N02 = [[Acute diarrhea resident survival guide#Antibiotic History|Recent antibiotics?]]}}
{{familytree | | | | | | | | | | | | | | | | | N01 | | | | | | | | | | | | | | N02 | | N01 = Symptomatic Rx | N02 = Any recent antibiotic useage}}
{{familytree | | | | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | |,|-|-|-|-|^|-|-|-|-|.| |}}
{{familytree | | | | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | |,|-|-|-|-|^|-|-|-|-|.| |}}
{{familytree | | | | | | | | | | | | O01 | | | | | | | | O02 | | | | O03 | | | | | | | | O04 | O01 = Resolved | O02 = Unresolved | O03 = NO | O04 = YES}}
{{familytree | | | | | | | | | | | | O01 | | | | | | | | O02 | | | | O03 | | | | | | | | O04 | O01 = Resolved | O02 = Unresolved | O03 = NO | O04 = YES}}
Line 63: Line 97:
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |!| | | | | P01 | | | | | P02 | P01 = Negative [[clostridium difficile|C-diff]] | P02 = Positive [[clostridium difficile|C-diff]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |!| | | | | P01 | | | | | P02 | P01 = Negative [[clostridium difficile|C-diff]] | P02 = Positive [[clostridium difficile|C-diff]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | | | | | |!| |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | | | | | |!| |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | R01 | | | | | | | | R02 | R01 = [[Stool culture]], followed by [[Acute diarrhea resident survival guide#Emperical Antibiotics|empiric ABx]]| R02 = [[Clostridium difficile medical therapy|Metronidazole/Vancomycin]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | R01 | | | | | | | | R02 | R01 = [[Stool culture]] | R02 = [[Clostridium difficile medical therapy|Metronidazole/Vancomycin]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | |!| | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | R03 | | | | | | | | | | | R03 = <div style="float: left; text-align: left; line-height: 150% "> '''Emperical antibiotic trial:'''
----
❑ Oral [[ciprofloxacin]] 500 mg BD X 3-5 days OR<br> ❑ Oral  [[levofloxacin]] 500 mg OD X 3-5 days OR<br> ❑  Oral [[norfloxacin]] 400 mg BD X 3-5 days OR<br> ❑ Oral azithromycin 500 mg OD X 3 days OR<br> ❑  erythromycin 500 mg BD X 5 days <br>
</div>}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |,|-|-|^|-|-|.| | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |,|-|-|^|-|-|.| | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | S01 | | | | S02 | | S01 = Negative culture | S02 = Positive culture}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | S01 | | | | S02 | | S01 = Negative culture | S02 = Positive culture}}
Line 71: Line 110:
{{familytree | | | | | | | | | | | | | | | | | | | | | | U01 | | | | U02 | | | | |!| | | | U01 = Negative | U02 = Positive}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | U01 | | | | U02 | | | | |!| | | | U01 = Negative | U02 = Positive}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | V01 | | | | | | | V02 | | | V01 = Consider imaging/scope | V02 = [[Acute diarrhea resident survival guide#Specific Antibiotics|Rx per results]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | V01 | | | | | | | V02 | | | V01 = Consider imaging/scope | V02 = [[Acute diarrhea resident survival guide#Specific Antibiotics|Specific antibiotics as per results]]}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | }}
{{familytree | | | | | | | | | | | | | | | | | | | | | | V03 | V03 = Rule out [[IBD]], [[colon cancer]], [[diverticulitis]], [[appendicitis]] etc.}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | V03 | V03 = Rule out [[IBD]], [[colon cancer]], [[diverticulitis]], [[appendicitis]] etc.}}
{{familytree/end}}
{{familytree/end}}
===History and Physical Examination===
* H/O : Onset, duration, stool frequency, type, volume, bloody, abdominal pain/cramps, nausea, vomiting, underlying medical conditions, radiation exposure and medications profile.
* Epidemiological clues : Travel H/O, dietary H/O, outbreaks, seasons, institutionalization and sexual H/O.
* PE : General status, level of consciousness, eyes, mucosa, ability to drink, skin turgor, pulse, blood pressure and respiratory rate.


===Evaluation of Volume Status by Dhaka Method===
===Evaluation of Volume Status by Dhaka Method===
Line 103: Line 137:
† Some dehydration = At least two signs, including at least one key sign (*) are present. <BR>
† Some dehydration = At least two signs, including at least one key sign (*) are present. <BR>
‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present.
‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present.
===Altered Diet===
* Stop lactose products, avoid alcohol and high osmolar supplements.
* Drink 8-10 large glasses of clear fluids, preferably sugar containing fluids like fruit juices and soft drinks.
* Eat frequent small meals like rice, potato, banana, pastas etc.


===Oral Rehydration Therapy===
===Oral Rehydration Therapy===
Line 117: Line 146:
* Some dehydration : Hydration should be restored by administering ORT at a volume of 50-100 mL/kg.
* Some dehydration : Hydration should be restored by administering ORT at a volume of 50-100 mL/kg.
* Severe dehydration : As the patient's clinical condition stabilizes and his/her level of consciousness returns to normal, therapy can be changed to ORT.  A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid.  The intravenous line should remain in place until it is certain there is successful transition to ORT. ORT therapy is started at a volume of 100 mL/kg over 4 hours.  Additional ORS is given to replace ongoing loss of stool.  At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour.
* Severe dehydration : As the patient's clinical condition stabilizes and his/her level of consciousness returns to normal, therapy can be changed to ORT.  A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid.  The intravenous line should remain in place until it is certain there is successful transition to ORT. ORT therapy is started at a volume of 100 mL/kg over 4 hours.  Additional ORS is given to replace ongoing loss of stool.  At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour.
===Warning Signs===
* Temperature ≥38.5ºC (101.3ºF)
* Severe abdominal pain
* Bloody diarrhea
* Passage of ≥6 unformed stools per 24 hours
* Severe dehydration
* Acute presentation of persistent diarrhea
* Diarrhea in the elderly (≥70 years of age)
* Immunocompromised
* Hospital-acquired
===Anti-motility Drugs===
* [[Loperamide]] : The dose is two tablets (4 mg) initially, then 2 mg after each unformed stool, not to exceed 16 mg/day for ≤2 days.
* [[Bismuth subsalicylate]] : This has also been used for symptomatic treatment of acute diarrhea.  Though not as effective as loperamide, it may be used in patients with significant fever and dysentery, where loperamide is contraindicated.  The dose is 30 mL or two tablets every 30 minutes for eight doses.
*  [[Diphenoxylate]] : Dont use it, as it has central opiate effects and may cause cholinergic side effects.  In addition, patients should be cautioned that treatment with these agents may mask the amount of fluid lost, since fluid may pool in the intestine.
===Antibiotic History===
* All antibiotics, including [[metronidazole]] and [[vancomycin]], can predispose to C. difficile and should be evaluated in the management of acute diarrhea.
* The antibiotics most frequently implicated in predisposition to C. difficile infection are [[fluoroquinolones]], [[clindamycin]], [[cephalosporins]], and [[penicillins]].
* Other possible associations are [[macrolides]], [[trimethoprim]], [[sulfonamides]], [[aminoglycosides]], [[tetracyclines]], [[chloramphenicol]] etc.
===Empirical Antibiotics===
* Fluoroquinolone : Oral [[ciprofloxacin]] 500 mg BD / [[norfloxacin]] 400 mg BD / [[levofloxacin]] 500 mg OD X for 3-5 days.
* Macrolides : Oral [[azithromycin]] 500 mg OD X 3 days / [[erythromycin]] 500 mg BD X 5 days are alternative agents, particularly if fluoroquinolone resistance is suspected.


===Specific Antibiotics===
===Specific Antibiotics===
Line 154: Line 158:
* For acute diarrhea, maintaining adequate intravascular volume and correcting fluid and electrolyte disturbances take priority over identifying the causative agent from detailed history and clinical findings, including stool characteristics.  
* For acute diarrhea, maintaining adequate intravascular volume and correcting fluid and electrolyte disturbances take priority over identifying the causative agent from detailed history and clinical findings, including stool characteristics.  
* Assess ABCD periodically depending on the patient status and check for any warning signs during the course of management.
* Assess ABCD periodically depending on the patient status and check for any warning signs during the course of management.
* When using normal saline due to unavailability of ringer lactate in diarrhea patients, ORT should be initiated as soon as they are able to drink, to replace bicarbonate and potassium losses.
* When using normal saline due to unavailability of ringer lactate in diarrhea patients, [[oral rehydration therapy]] ORT should be initiated as soon as they are able to drink, to replace bicarbonate and potassium losses.
* A nasogastric tube can be used to deliver ORT in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid.
* Always check for warning signs before initiating anti-motility drugs.
* Use [[bismuth subsalicylate]] for symptomatic treatment of acute diarrhea with significant fever and dysentery, where loperamide is contraindicated.
* Stool cultures are usually unnecessary for immune-competent patients who present with watery diarrhea, but may be necessary when there is clinical and/or epidemiological suspicion of a causative agent, particularly during the early days of outbreaks/epidemics.  
* Stool cultures are usually unnecessary for immune-competent patients who present with watery diarrhea, but may be necessary when there is clinical and/or epidemiological suspicion of a causative agent, particularly during the early days of outbreaks/epidemics.  
* Report to the public health authorities in case of suspected outbreaks.
* Report to the public health authorities in case of suspected outbreaks.
Line 161: Line 168:
* Don't treat patients with severe diarrheal dehydration using 5% dextrose with 1/4 normal saline, as using solutions with lower amounts of sodium (such as 38.5 mmol/L in 1/4 saline with 5% dextrose ) would lead to sudden and severe hyponatremia with a high risk of death.  
* Don't treat patients with severe diarrheal dehydration using 5% dextrose with 1/4 normal saline, as using solutions with lower amounts of sodium (such as 38.5 mmol/L in 1/4 saline with 5% dextrose ) would lead to sudden and severe hyponatremia with a high risk of death.  
* ORT is contraindicated in the initial management of severe dehydration and also in patients with frequent and persistent vomiting (more than four episodes per hour), and painful oral conditions such as moderate to severe thrush.
* ORT is contraindicated in the initial management of severe dehydration and also in patients with frequent and persistent vomiting (more than four episodes per hour), and painful oral conditions such as moderate to severe thrush.
* Loperamide should be avoided in patients with significant abdominal pain, fever and bloody diarrhea that suggests inflammatory diarrhea.
* [[Loperamide]] should be avoided in patients with significant abdominal pain, fever and bloody diarrhea that suggests inflammatory diarrhea.
* Dont use [[diphenoxylate]], as it has central opiate effects and may cause cholinergic side effects.  In addition, patients should be cautioned that treatment with these agents may mask the amount of fluid lost, since fluid may pool in the intestine.


==References==
==References==

Revision as of 17:19, 31 December 2013

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Definition

Three or more bowel movements daily are considered to be abnormal, and the upper limit of stool weight is generally agreed to be 200 g daily.[1] Acute diarrhea has a duration of less than four weeks. Most cases of acute diarrhea are due to infections with viruses and bacteria and are self-limited. The evaluation of patients for a noninfectious etiology should be considered as the course of diarrhea persists and becomes chronic.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Inflammatory Causes

Noninflammatory Causes

Management

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adults with acute diarrhea (<4 weeks)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obtain a brief history:

❑ Onset
❑ Duration
❑ Pattern (Continuous or intermittent)
❑ Type (Watery, bloody or fatty)
❑ Fever
❑ Abdominal pain
❑ Nausea and vomiting
❑ Weight loss
❑ Epidemiological factors (Travel H/O, dietary H/O, outbreaks, seasons, institutionalization or sexual H/O)
❑ Previous evaluations (Medications, radiation therapy or surgery)
❑ Underlying medical condition (Cancer, diabetes, hyperthyroidism or other conditions)


Examine the patient


❑ General condition
❑ Level of consciousness
❑ Ability to drink
❑ Pulse
❑ Blood pressure
❑ Respiratory rate
❑ Eyes
❑ Skin turgor

❑ Mucosa
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessment of volume status
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No dehydration
 
 
 
 
 
 
 
 
 
 
 
 
 
Some dehydration
 
 
 
 
 
 
 
 
 
 
 
 
 
Severe dehyration
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start altered diet:

❑ Stop lactose products
❑ Avoid alcohol and high osmolar supplements
❑ Drink 8-10 large glasses of clear fluids (Fruit juices, soft drinks etc)
❑ Eat frequent small meals (Rice, potato, banana, pastas etc)


Can start oral rehydration therapy (ORT) for replacement of stool losses
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Start ORT at a volume of 50-100 mL/kg
❑ Start altered diet
❑ Reassess status every 4 hr
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Start IV fluids: Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use normal saline
CBC
Electrolytes
❑ Assess status every 15 mins until strong pulse felt and then every 1 hr
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient stable and able to drink
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check for the following warning signs:

❑ Temperature ≥38.5ºC (101.3ºF)
❑ Severe abdominal pain
❑ Bloody diarrhea
❑ Passage of ≥6 unformed stools per 24 hours
❑ Acute presentation of persistent diarrhea
❑ Diarrhea in the elderly (≥70 years of age)
❑ Immunocompromised
❑ Hospital-acquired

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Start ORT at a volume of 100 mL/kg over 4 hour
❑ Calculate the continuing stool and emesis losses every hour for additional maintenance ORT therapy ❑ Reassess status every 4 hr
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anti-motility drugs:
Loperamide: Two tablets (4 mg) initially, then 2 mg after each unformed stool OR
Bismuth subsalicylate, 30 mL or two tablets every 30 minutes for eight doses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess the pt in 24 hrs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resolved
 
 
 
 
 
 
 
 
 
 
 
 
 
Unresolved
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gradually add solid foods to diet
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order investigations:

CBC
Serum electrolytes
Urinalysis
BUN
Creatinine
Fecal occult blood (OBT)
❑ fecal WBC

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anemia, thrombocytopenia, elevated BUN and creatinine
 
 
 
 
 
YES
 
 
 
E. coli O157:H7 suspicion, stool culture and ELISA for Shiga toxin and supportive care
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative fecal WBC/OBT
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive fecal WBC/OBT
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-inflammatory
 
 
 
 
 
 
 
 
 
 
 
 
 
Inflammatory
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Symptomatic Rx
 
 
 
 
 
 
 
 
 
 
 
 
 
Any recent antibiotic useage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resolved
 
 
 
 
 
 
 
Unresolved
 
 
 
NO
 
 
 
 
 
 
 
YES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative C-diff
 
 
 
 
Positive C-diff
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stool culture
 
 
 
 
 
 
 
Metronidazole/Vancomycin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Emperical antibiotic trial:

❑ Oral ciprofloxacin 500 mg BD X 3-5 days OR
❑ Oral levofloxacin 500 mg OD X 3-5 days OR
❑ Oral norfloxacin 400 mg BD X 3-5 days OR
❑ Oral azithromycin 500 mg OD X 3 days OR
❑ erythromycin 500 mg BD X 5 days

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative culture
 
 
 
Positive culture
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check ova and parasites
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative
 
 
 
Positive
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider imaging/scope
 
 
 
 
 
 
Specific antibiotics as per results
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rule out IBD, colon cancer, diverticulitis, appendicitis etc.

Evaluation of Volume Status by Dhaka Method

Assessment No dehydration Some dehydration Severe dehydration
General condition Normal Irritable/less active* Lethargic/comatose§
Eyes Normal Sunken
Mucosa Normal Dry
Thirst Normal Thirsty Unable to drink§
Radial pulse Normal Low volume* Absent/ uncountable§
Skin turgor Normal Reduced

† Some dehydration = At least two signs, including at least one key sign (*) are present.
‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present.

Oral Rehydration Therapy

For each degree of dehydration, treatment is divided into two phases:

  • Rehydration phase : Water and electrolytes are administered to replace losses. The fluid deficit is replaced quickly over three to four hours, returning the patient to a euvolemic state.
  • Maintenance phase : Maintenance fluid therapy to take care of ongoing losses once rehydration is achieved (along with appropriate nutrition).
  • No dehydration : ORT is used to maintain hydration by replacement of stool losses.
  • Some dehydration : Hydration should be restored by administering ORT at a volume of 50-100 mL/kg.
  • Severe dehydration : As the patient's clinical condition stabilizes and his/her level of consciousness returns to normal, therapy can be changed to ORT. A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid. The intravenous line should remain in place until it is certain there is successful transition to ORT. ORT therapy is started at a volume of 100 mL/kg over 4 hours. Additional ORS is given to replace ongoing loss of stool. At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour.

Specific Antibiotics

Do's

  • For acute diarrhea, maintaining adequate intravascular volume and correcting fluid and electrolyte disturbances take priority over identifying the causative agent from detailed history and clinical findings, including stool characteristics.
  • Assess ABCD periodically depending on the patient status and check for any warning signs during the course of management.
  • When using normal saline due to unavailability of ringer lactate in diarrhea patients, oral rehydration therapy ORT should be initiated as soon as they are able to drink, to replace bicarbonate and potassium losses.
  • A nasogastric tube can be used to deliver ORT in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid.
  • Always check for warning signs before initiating anti-motility drugs.
  • Use bismuth subsalicylate for symptomatic treatment of acute diarrhea with significant fever and dysentery, where loperamide is contraindicated.
  • Stool cultures are usually unnecessary for immune-competent patients who present with watery diarrhea, but may be necessary when there is clinical and/or epidemiological suspicion of a causative agent, particularly during the early days of outbreaks/epidemics.
  • Report to the public health authorities in case of suspected outbreaks.

Don'ts

  • Don't treat patients with severe diarrheal dehydration using 5% dextrose with 1/4 normal saline, as using solutions with lower amounts of sodium (such as 38.5 mmol/L in 1/4 saline with 5% dextrose ) would lead to sudden and severe hyponatremia with a high risk of death.
  • ORT is contraindicated in the initial management of severe dehydration and also in patients with frequent and persistent vomiting (more than four episodes per hour), and painful oral conditions such as moderate to severe thrush.
  • Loperamide should be avoided in patients with significant abdominal pain, fever and bloody diarrhea that suggests inflammatory diarrhea.
  • Dont use diphenoxylate, as it has central opiate effects and may cause cholinergic side effects. In addition, patients should be cautioned that treatment with these agents may mask the amount of fluid lost, since fluid may pool in the intestine.

References

  1. Sleisenger, Marvin H.; Feldman, Mark; Friedman, Lawrence S. (Lawrence Samuel); Brandt, Lawrence J. (2010). Sleisenger and Fordtran's gastrointestinal and liver disease : pathophysiology, diagnosis, managemen. Philadelphia , PA: Saunders/Elsevier. ISBN 1-4160-6189-4.


Template:WikiDoc Sources